Jefferies Group's TNGX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 2.01 M shares of Tango Therapeutics, Inc. (TNGX) worth $62.85 M, representing 0.41% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in TNGX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Tango Therapeutics (TNGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tango Therapeutics (TNGX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +2.01 M | New Buy | 2.01 M | $31.26 |
Jefferies Group's Tango Therapeutics Investment FAQs
Jefferies Group first purchased Tango Therapeutics, Inc. (TNGX) in Q2 2026, acquiring 2,010,534 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Tango Therapeutics, Inc. (TNGX) for 1 quarters since Q2 2026.
Jefferies Group's largest addition to Tango Therapeutics, Inc. (TNGX) was in Q2 2026, adding 2,010,534 shares worth $62.85 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 2,010,534 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $62.85 M.
As of the Q2 2026 filing, Tango Therapeutics, Inc. (TNGX) represents approximately 0.41% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Tango Therapeutics, Inc. (TNGX) was 2,010,534 shares, as reported at the end of Q2 2026.